Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

5(62.5%)

Early Phase 1

3(37.5%)

8Total

Phase 1(5)

Early Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01640288Phase 1Completed

Imaging Regional Lung Defect Severity

Role: lead

NCT03237364Early Phase 1Completed

Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)

Role: lead

NCT03315065Early Phase 1Completed

19F Thoracic Radiotherapy for Lung Cancer

Role: lead

NCT03532334Early Phase 1Withdrawn

Comparison of 133Xe Scintigraphy With 19F MRI

Role: lead

NCT01621386Phase 1Completed

Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)

Role: lead

NCT02019251Phase 1Completed

Lung Transplant Subjects Using 19F MRI

Role: lead

NCT01731015Phase 1Completed

Imaging Lung Function Using Oxygen Enhanced MRI

Role: lead

NCT01710449Phase 1Completed

Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen

Role: lead

All 8 trials loaded